Report from Gambro's Annual General Meeting, March 27, 2000

Report from Gambro's Annual General Meeting, March 27, 2000 Stockholm, Sweden, March 27, 2000 - Gambro AB (OM Stockholm Exchange: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, today reported the following decisions taken at the Annual General Meeting. Board of Directors Claes Dahlbäck, Gösta Gahrton, Peter H Grassmann, Juha P Kokko, Mikael Lilius, Håkan Mogren, Sven Nyman and Björn Svedberg were reelected members of the Board. At the statutory Board meeting following the Annual General Meeting, Claes Dahlbäck was elected Chairman and Håkan Mogren was elected Vice Chairman. Dividend The Meeting approved a dividend for 1999 of SEK 1.10 per share, with a record date of March 30, 2000. With this record date, dividends are expected to be paid from VPC (The Swedish Central Securities Depository and Clearing Organisation) on April 4, 2000. Purchase and sale of the Company's own shares The proposed authority for the Board to decide on the purchase and sale of the Company's own shares was approved. In short this includes authority for the Board to decide on the acquisition of own shares subject to certain conditions as well as authority to dispose of own shares subject to certain conditions. For further information please contact: Bengt Modéer, Senior Vice President, Corporate Communications, tel. +46-8-613 65 00, +46-70-513 65 33 Anna Augustson, European Investor Relations Manager, tel. +46-8-613 65 35, +46-70-513 65 34 ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/2000/03/27/20000327BIT00550/bit0001.doc http://www.bit.se/bitonline/2000/03/27/20000327BIT00550/bit0002.pdf